AstraZeneca ends another Calquence trial early

AstraZeneca ends another Calquence trial early

Source: 
Pharmaforum
snippet: 

For the second time in the space of a month AstraZeneca has stopped a trial of its chronic lymphocytic leukaemia (CLL) drug Calquence (acalabrutinib) early following positive results.